Skip to main content
Top
Published in: Current Diabetes Reports 9/2019

01-09-2019 | Insulins | Rebuttal

Rebuttals to “The Debate on Insulin vs. Non-insulin Use in the Hospital Setting—Continued Use of Insulin or Time to Revise the Guidelines?”

Authors: Smita Kumar, Mark E. Molitch, Francisco J. Pasquel, Maya Fayfman, Guillermo E. Umpierrez

Published in: Current Diabetes Reports | Issue 9/2019

Login to get access

Excerpt

Title: Debate on Insulin vs. Non-insulin Use in the Hospital Setting—Is It Time to Revise the Guidelines for the Management of Inpatient Diabetes?
Metadata
Title
Rebuttals to “The Debate on Insulin vs. Non-insulin Use in the Hospital Setting—Continued Use of Insulin or Time to Revise the Guidelines?”
Authors
Smita Kumar
Mark E. Molitch
Francisco J. Pasquel
Maya Fayfman
Guillermo E. Umpierrez
Publication date
01-09-2019
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 9/2019
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-019-1185-7

Other articles of this Issue 9/2019

Current Diabetes Reports 9/2019 Go to the issue

Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors)

Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application

Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)

Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.